ALLERGAN$91.27
+0.02
| Last Trade: |
91.27 |
| Trade Time: |
May 16 3:55 PM Eastern Daylight Time |
| Change: |
0.02 (0.02 %) |
| Prev Close: |
91.25 |
| Open: |
91.66 |
| Bid: |
91.23 |
| Ask: |
91.25 |
Quotes displayed are delayed by 15 minutes. Market data is provided by Telvent DTN
|
Date |
Name |
Title |
Volume |
Trade Price |
Holding Change |
|
5/7/2012
|
Endicott David J.
|
CVP and President, AGN Med
|
-27,500
|
$93.81
|
-57.47%
|
|
5/7/2012
|
Endicott David J.
|
CVP and President, AGN Med
|
15,000
|
$40.16
|
73.70%
|
|
5/7/2012
|
Endicott David J.
|
CVP and President, AGN Med
|
12,500
|
$59.13
|
35.36%
|
|
5/4/2012
|
EDWARDS JEFFREY L
|
EVP, Fin & Bus. Dev., CFO
|
60,000
|
$40.16
|
108.04%
|
|
5/4/2012
|
EDWARDS JEFFREY L
|
EVP, Fin & Bus. Dev., CFO
|
-99,462
|
$93.01
|
-86.09%
|
Data provided by Insiderslab.com. To read detailed Insider Trading Research Report for (AGN), click here.
-
Allergan Beats on Revs, Misses on EPS - Analyst Blog
Read More »
-
Earnings Preview: Allergan - Analyst Blog
Read More »
-
Rockin' REITs
Read More »
-
Let's take a look at a few stocks that have recently entered overbought territory because these could be candidates for a short-term pullback when the broad market rally ends.
Read More »
-
Medicis is well-run, but arguably too risky to stay independent.
Read More »
-
The beauty industry continues to do well in a volatile market.
Read More »
Free Reports
|
|
